52.15.63.145
dgid:
enl:
npi:0

-Advertisement-

-Advertisement-

Home Usher Syndrome: A Physician’s Perspective

Ophthalmology

Usher Syndrome: A Physician’s Perspective

Watch Now

By rd360stg

Recalcitrant TED responsive to teprotumumab

By rd360stg

Teprotumumab adherence rates are high in patients with TED

By rd360stg

Teprotumumab-related adverse events common but mild

By rd360stg

How did pandemic-related teprotumumab treatment delays impact outcomes?

-Advertisement-

-Advertisement-

-Advertisement=-

By rd360stg

Teprotumumab increases tear production in patients with TED

By rd360stg

Clinical Trials for Retinal Disease Gene Therapies is Driving the Need for Genetic Testing

By rd360stg

Does smoking decrease effectiveness of teprotumumab in thyroid eye disease?

By rd360stg

Baseline imaging may predict teprotumumab response

-Advertisement-

-Advertisement-

-Advertisement=-

By rd360stg

Statins improves Graves’ orbitopathy outcomes in patients with active eye disease

By rd360stg

TED may result in changes across the entire face

By rd360stg

FDA approves Verkazia for treatment of vernal keratoconjunctivitis

By rd360stg

Is teprotumumab better than steroids in TED associated compressive optic neuropathy?

-Advertisement-

-Advertisement-

Videos

Usher Syndrome: A Physician’s Perspective

30 Nov, 2021

-Advertisement-

-Advertisement-

Contact

Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809

+908-505-8899

[email protected]

Social Links

© 2024 Med Journal 360™ is a trademark of International Healthcare Media, LLC. All rights Reserved

-Advertisement-

-Advertisement-